Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Notices 43739

receive the Medicare premium bill and

pay it on behalf of a Medicare

beneficiary. Frequency: On occasion;

Affected Public: Individuals or

Households; Number of Respondents:

15,000; Total Annual Responses:

15,000; Total Annual Hours: 6,250.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, E-mail your request,

including your address and phone

number, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB desk officer: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: August 5, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, Division of

HCFA Enterprise Standards, Health Care

Financing Administration.

[FR Doc. 97–21650 Filed 8–14–97; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Initial

Review Group (IRG) meeting:

Name of IRG: Clinical Trials Review

Committee.

Date: October 26–29, 1997.

Time: 7:00 p.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, Maryland

20814.

Contact Person: Dr. Joyce A. Hunter, 6701

Rockledge Drive, Rm. 7192, MSC 7924,

Bethesda, Maryland 20892, (301) 435–0287.

Purpose/Agenda: To review and evaluate

grant applications.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: August 8, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21624 Filed 8–14–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meeting:

Name of SEP: Jackson Heart Study

Feasibility Study (Telephone Conference

Call).

Date: September 3, 1997.

Time: 2:00 p.m.

Place: Two Rockledge Center, 6701

Rockledge Drive, Room 7214, Bethesda,

Maryland 20892.

Contact Person: C. James Scheirer, Ph.D.,

Two Rockledge Center, Room 7214, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0266.

Purpose/Agenda: To review and evaluate

contract proposals.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than

fifteen days prior to this meeting due to the

urgent need to meet timing limitations

imposed by the grant/contract review and

funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: August 8, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21625 Filed 8–14–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Dental Research;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Dental Research

Special Emphasis Panel (SEP) meeting:

Name of SEP: National Institute of Dental

Research Special Emphasis Panel—Review of

R01 (97–62).

Dates: September 4, 1997.

Time: 3:00 p.m.

Place: Natcher Building, Rm. 4AN–44F,

National Institutes of Health, Bethesda, MD

20892 (teleconference).

Contact Person: Dr. George Hausch, Chief,

Grants Review Section, 4500 Center Drive,

Natcher Building, Room 4AN–44F, Bethesda,

MD 20892, (301) 594–2372.

Purpose/Agenda: To evaluate and review

grant applications and/or contract proposals.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.121, Oral Diseases and

Disorders Research)

Dated: August 11, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21616 Filed 8–14–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases;

Meeting of the National Diabetes and

Digestive and Kidney Diseases

Advisory Council and Its

Subcommittees

Pursuant to Pub. L. 92–463, notice is

hereby given of a meeting of the

National Diabetes and Digestive and

Kidney Diseases Advisory Council and

its subcommittees, National Institute of

Diabetes and Digestive and Kidney

Diseases, on September 17–18, 1997.

The meeting of the full Council will be

open to the public on September 17,

from 8:30 a.m. to 12:00 p.m. in

Conference Room 6, Building 31C,

National Institutes of Health, Bethesda,

Maryland, to discuss administrative

issues relating to Council business and